乳腺癌保皮乳房切除即刻自体皮瓣重建后放疗与不放疗的患者报告及手术结局:1年MROC子研究
该研究比较乳腺癌保皮乳房切除联合即刻自体游离皮瓣重建后接受辅助放疗与未放疗患者1年时24个患者报告结局域及手术并发症。结果显示放疗组EORTC乳腺癌特异性问卷乳房症状显著更重(100分制差8分,P<.0001),但BREAST-Q等其他量表及手术并发症无统计学差异。
要点
- 放疗组EORTC乳房症状评分较未放疗组高8分(100分制,P<.0001)。
- BREAST-Q、疼痛、焦虑、抑郁等其余患者报告结局无统计学差异。
- 手术并发症少见且两组无差异,1年耐受性总体良好。
核心结论
- 即刻自体游离皮瓣重建后对新乳房行辅助放疗在术后1年耐受性良好,尽管放疗组癌症分期更高且手术及全身治疗更密集。
- EORTC乳腺癌特异性问卷显示放疗组新乳房症状更常见,但BREAST-Q未显示差异。
研究设计与样本
- 来自乳房切除重建结局联盟(MROC)研究数据库的回顾性比较研究,纳入2012至2015年在本机构手术的125例患者。
- 比较接受辅助放疗(64例)与未接受放疗(61例)患者术后1年24个患者报告结局域,并建立校正多因素模型纳入放疗技术数据、年龄、癌症分期、雌激素受体、化疗、乳房大小、体重指数和收入。
主要发现
- 术后1年,EORTC乳腺癌特异性生活质量问卷乳房症状在放疗组显著更重(100分制差8分,P<.0001),单因素和多因素模型均显著。
- EORTC手臂症状在单因素分析中有差异(100分制差20分,P=.0200),但多因素分析无统计学差异。
- 数字疼痛评定量表、BREAST-Q术后重建模块、PROMIS Profile 29、McGill疼痛问卷简表评分、广泛性焦虑障碍量表、患者健康问卷等其余结局两组无统计学差异。
- 手术并发症少见且两组无差异。
临床怎么用
- 对于保皮乳房切除联合即刻自体游离皮瓣重建的乳腺癌患者,辅助放疗在术后1年总体耐受性良好,但需关注EORTC问卷所评估的新乳房症状。
- 咨询时应告知患者放疗可能增加EORTC评估的乳房症状,但BREAST-Q等其他患者报告结局及手术并发症未见显著差异。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine whether adjuvant radiation therapy (RT) is associated with adverse patient-reported outcomes and surgical complications 1 year after skin-sparing mastectomy and immediate autologous free flap reconstruction for breast cancer. METHODS AND MATERIALS: We compared 24 domains of patient-reported outcome measures 1 year after autologous reconstruction between patients who received adjuvant RT and those who did not. A total of 125 patients who underwent surgery between 2012 and 2015 at our institution were included from the Mastectomy Reconstruction Outcomes Consortium study database. Adjusted multivariate models were created incorporating RT technical data, age, cancer stage, estrogen receptor, chemotherapy, breast size, body mass index, and income to determine whether RT was associated with outcomes. RESULTS: At 1 year after surgery, European Organisation for Research and Treatment of Cancer (EORTC) Breast Cancer-Specific Quality of Life Questionnaire breast symptoms were significantly greater in 64 patients who received RT (8-point difference on 100-point ordinal scale, P<.0001) versus 61 who did not receive RT in univariate and multivariate models. EORTC arm symptoms (20-point difference on 100-point ordinal scale, P=.0200) differed on univariate analysis but not on multivariate analysis. All other outcomes-including Numerical Pain Rating Scale, BREAST-Q (Post-operative Reconstruction Module), Patient-Report Outcomes Measurement Information System Profile 29, McGill Pain Questionnaire-Short Form (MPQ-SF) score, Generalized Anxiety Disorder Scale, and Patient Health Questionnaire-were not statistically different between groups. Surgical complications were uncommon and did not differ by treatment. CONCLUSIONS: RT to the neo-breast compared with no RT following immediate autologous free flap reconstruction for breast cancer is well tolerated at 1 year following surgery despite patients undergoing RT also having a higher cancer stage and more intensive surgical and systemic treatment. Neo-breast symptoms are more common in patients receiving RT by the EORTC Breast Cancer-Specific Quality of Life Questionnaire but not by the BREAST-Q. Patient-reported results at 1 year after surgery suggest RT following immediate autologous free flap breast reconstruction is well tolerated.
引用
- Cooke AL, Diaz-Abele J, Hayakawa T, et al. Radiation Therapy Versus No Radiation Therapy to the Neo-breast Following Skin-Sparing Mastectomy and Immediate Autologous Free Flap Reconstruction for Breast Cancer: Patient-Reported and Surgical Outcomes at 1 Year-A Mastectomy Reconstruction Outcomes Consortium (MROC) Substudy. Int J Radiat Oncol Biol Phys. 2017. PMID: 28816143. doi:10.1016/j.ijrobp.2017.05.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。